alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 23.1**

 

**INDEPENDENT AUDITORS’ CONSENT**

 

The Board of Directors 

Strategic Diagnostics Inc.: 

 

We consent to incorporation by reference in the registration statements (Nos. 33-20421, 333-21211 and 333-68107) on Form S-8 of Strategic Diagnostics Inc.of our report dated February 13, 2004, relating to the consolidated balance sheets of Strategic Diagnostics Inc. and subsidiaries as of December 31, 2003 and 2002, and the related consolidated statements of operations, stockholders’ equity andcomprehensive income and cash flows for each of the years in the three-year period ended December 31, 2003, which report appears in the December 31, 2003 annual report on Form 10-K of Strategic Diagnostics Inc. 

 

Our report dated February 13, 2004 contains an explanatory paragraph thatdescribes the adoption of Statement of Financial Accounting Standards No. 142, “Goodwill and Other Intangibles”, effective January 1, 2002. 

 

/s/    KPMG LLP 

 

Philadelphia, Pennsylvania 

March 23, 2004
|   | EXHIBIT 32.1 |   |
|--------|--------------|--------|

|   |
|--------|

|   | CERTIFICATION OF CHIEF EXECUTIVEOFFICER PURSUANT TO 18 U.S.C. SECTION1350 |   |
|--------|---------------------------------------------------------------------------|--------|

| In connection with the Quarterly Report of Air-Q Wi-Fi Corporation (the "Company") onForm 10-QSB for the period ending September 30, 2003, as filed with the Securities andExchange Commission on the date hereof (the "Report"), I, David Loflin, President of theCompany, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a)and (b) of Section 1350, Chapter 63 of Title 18, United States Code), that: |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934; and                               |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | The information contained in the Report fairly presents, in all material respects, thefinancial condition and result of operations of the Company. |

|   |
|--------|

| Dated: November 19, 2003 | /s/ DAVID LOFLIN |   |
|--------------------------|------------------|--------|

|   | DavidLoflinPresident |   |
|--------|----------------------|--------|
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

JUDGMENT RENDERED MAY 22, 2013

NO. 03-12-00672-CR

Stacey Bo Williamson, Appellant

v.

The State of Texas, Appellee

APPEAL FROM THE 27TH DISTRICT COURT OF BELL COUNTY

BEFORE CHIEF JUSTICE JONES, JUSTICES GOODWIN AND FIELD

AFFIRMED -- OPINION BY CHIEF JUSTICE JONES

THIS CAUSE came on to be heard on the record of the court below, and the same being 

considered, it is the opinion of this Court that there was no error requiring reversal of the trial 

court’s judgment of conviction: IT IS ORDERED, ADJUDGED AND DECREED by the 

Court that the trial court’s judgment of conviction is in all things affirmed; and it appearing that 

the appellant is indigent and unable to pay costs, that no adjudication as to costs is made; and 

that this decision be certified below for observance.
### FOR PUBLICATION


### UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT



#  D IDAR S INGH , Petitioner, No. 04-70300

v. Agency No.



#  A79-612-780 A LBERTO R. G ONZALES , Attorney General, ORDER

Respondent. 

# 

Filed September 7, 2007

Before: Michael Daly Hawkins and Marsha S. Berzon, Circuit Judges, and Roslyn O. Silver,* District Judge.

ORDER

The Petitioner’s Motion for Costs and Fees under the Equal Access to Justice Act, 28 U.S.C. § 2412(d) ( “EAJA ”), is GRANTED.

1. The Court notes that Respondent’s primary argument— that only litigation positions of the Department of Homeland Security ( “DHS ”) before this Court, and not decisions of Immigration Judges ( “IJs ”) and the Bureau of Immigration Appeals ( “BIA ”), are pertinent with regard to whether the government’s position in this case was substantially justified — was squarely rejected by this Court in Thangaraja v. Gonzales, 428 F.3d 870, 873 (9th Cir. 2005) ( “We reject this contention, which completely lacks justification. Pursuant to the EAJA, the BIA and IJ decisions we review are as much the

*The Honorable Roslyn O. Silver, United States District Judge for the District of Arizona, sitting by designation.

11919‘position of the United States’ as is the DHS’ litigation position.”).

It is the responsibility of the Department of Justice and its lawyers to be aware when its positions have been rejected by the court. While it is acceptable to make a rejected argument for purposes of preserving it for en banc or Supreme Court consideration while acknowledging that it has been rejected by the court, it is not acceptable to repeat an argument alreadyrejected without acknowledging the case that rejected it, particularly where it is the Department of Justice itself that was involved in earlier case. Another such repetition of this sameargument in this court will be considered sanctionable behavior.

2. Considering the BIA’s position as well as the arguments made in this court, the Government’s position in this action was not substantially justified. See Singh v. Gonzales

, No. 04-70300, mem. at 2-4 (9th Cir. Dec. 5, 2006). Because Petitioner was the prevailing party in this action and the fees requested are consistent with the statute and reasonable, see id. at 4, attorney’s fees and costs are awarded to Petitioner in the amount of $3807.04. 11920 S INGH v. G ONZALESPRINTED FOR ADMINISTRATIVE OFFICE—U.S. COURTS BY THOMSON/WEST—SAN FRANCISCO

The summary, which does not constitute a part of the opinion of the court, is copyrighted © 2007 Thomson/West.
<TABLE> <S> <C>

<ARTICLE>           5
<MULTIPLIER>        1,000

<S>                                     <C>
<PERIOD-TYPE>                           12-MOS
<FISCAL-YEAR-END>                       Dec-31-1997
<PERIOD-START>                          Jan-01-1997
<PERIOD-END>                            Dec-31-1997
<CASH>                                        2,292
<SECURITIES>                                      0
<RECEIVABLES>                                 4,727
<ALLOWANCES>                                  1,358
<INVENTORY>                                       0
<CURRENT-ASSETS>                              5,896
<PP&E>                                          156
<DEPRECIATION>                                    0
<TOTAL-ASSETS>                                6,052
<CURRENT-LIABILITIES>                         3,065
<BONDS>                                           0
<COMMON>                                      5,802
<PREFERRED-MANDATORY>                             0
<PREFERRED>                                       0
<OTHER-SE>                                        0
<TOTAL-LIABILITY-AND-EQUITY>                  6,052
<SALES>                                           0
<TOTAL-REVENUES>                             21,121
<CGS>                                             0
<TOTAL-COSTS>                                13,038
<OTHER-EXPENSES>                             10,222
<LOSS-PROVISION>                                  0
<INTEREST-EXPENSE>                             (110)
<INCOME-PRETAX>                              (2,029)
<INCOME-TAX>                                   (139)
<INCOME-CONTINUING>                          (1,890)
<DISCONTINUED>                                    0
<EXTRAORDINARY>                                   0
<CHANGES>                                         0
<NET-INCOME>                                 (1,890)
<EPS-PRIMARY>                                 (0.19)
<EPS-DILUTED>                                 (0.19)


</TABLE>
Form 8027-T

Department of the Treasury 

Internal Revenue Service 

Transmittal of Employer's Annual 

Information Return of Tip Income and Allocated Tips

▶ For Privacy Act and Paperwork Reduction Act Notice, see

the Instructions for Form 8027.

OMB No. 1545-0714

2012

Type or print employer’s 

name, address, and 

employer identification 

number as shown on 

Form 941.

Employer’s name

Number and street (or P.O. box number, if mail is not delivered to street address.) Apt. or suite no.

City or town, state, and ZIP code

Employer identification number

Number of accompanying Forms 8027

Use Form 8027-T to send Forms 8027 to the Internal 

Revenue Service if you have more than one 

establishment for which you have to file Form 8027.

File Form 8027-T along with accompanying Forms 

8027 with the Department of the Treasury, Internal 

Revenue Service, Cincinnati, OH 45999 by 

February 28, 2013.

Cat. No. 61006A Form 8027-T (2012)
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<CURRENCY>   NO
       
<S>                             <C>                     <C>
<PERIOD-TYPE>                   9-MOS                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1998             DEC-31-1997
<PERIOD-START>                             JAN-01-1998             JAN-01-1997
<PERIOD-END>                               SEP-30-1998             SEP-30-1997
<EXCHANGE-RATE>                                      1                       1 
<CASH>                                         106,877                 140,269
<SECURITIES>                                         0                       0
<RECEIVABLES>                                        0                       0
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                                     0                       0
<PP&E>                                       2,560,521               2,513,665
<DEPRECIATION>                                       0                       0
<TOTAL-ASSETS>                               2,675,380               2,663,242
<CURRENT-LIABILITIES>                                0                       0
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                             0                       0
<OTHER-SE>                                   2,675,380               2,663,242
<TOTAL-LIABILITY-AND-EQUITY>                 2,675,380               2,663,242
<SALES>                                              0                       0
<TOTAL-REVENUES>                                 6,183                 528,654
<CGS>                                                0                       0
<TOTAL-COSTS>                                        0                       0
<OTHER-EXPENSES>                                27,088                  34,585
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                   0                       0
<INCOME-PRETAX>                               (20,905)                 494,069
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                           (20,905)                 494,069
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                  (20,905)                 494,069
<EPS-PRIMARY>                                        0                       0
<EPS-DILUTED>                                        0                       0
        

</TABLE>
##### 



EXHIBIT 32.2
 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
  (1)
    
    The Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and(2)
    
    The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company at and for
the periods indicated.
  /s/ Cameron R. NelsonCameron R. NelsonVice President, Finance and Chief Financial Officer
(Principal Financial and Accounting Officer)
<TABLE> <S> <C>

<ARTICLE>                              5
       
<S>                                    <C>                <C>
<PERIOD-TYPE>                          3-MOS              12-MOS
<FISCAL-YEAR-END>                      DEC-31-1998        DEC-31-1997
<PERIOD-START>                         JAN-01-1998        JAN-01-1997
<PERIOD-END>                           MAR-30-1998        DEC-31-1997
<CASH>                                      0 <F1>             0 <F1>
<SECURITIES>                                0 <F1>             0 <F1>
<RECEIVABLES>                               0 <F1>             0 <F1>
<ALLOWANCES>                                0 <F1>             0 <F1>
<INVENTORY>                                 0 <F1>             0 <F1>
<CURRENT-ASSETS>                            0 <F1>             0 <F1>
<PP&E>                                      0 <F1>             0 <F1>
<DEPRECIATION>                              0 <F1>             0 <F1>
<TOTAL-ASSETS>                              0 <F1>             0 <F1>
<CURRENT-LIABILITIES>                       0 <F1>             0 <F1>
<BONDS>                                     0 <F1>             0 <F1>
<COMMON>                                    0 <F1>             0 <F1>
<PREFERRED-MANDATORY>                       0 <F1>             0 <F1>
<PREFERRED>                                 0 <F1>             0 <F1>
<OTHER-SE>                                  0 <F1>             0 <F1>
<TOTAL-LIABILITY-AND-EQUITY>                0 <F1>             0 <F1>
<SALES>                                     0 <F2>             0 <F2>
<TOTAL-REVENUES>                            0 <F2>             0 <F2>
<CGS>                                       0 <F2>             0 <F2>
<TOTAL-COSTS>                               0 <F2>             0 <F2>
<OTHER-EXPENSES>                            0 <F2>             0 <F2>
<LOSS-PROVISION>                            0 <F2>             0 <F2>
<INTEREST-EXPENSE>                          0 <F2>             0 <F2>
<INCOME-PRETAX>                             0 <F2>             0 <F2>
<INCOME-TAX>                                0 <F2>             0 <F2>
<INCOME-CONTINUING>                         0 <F2>             0 <F2>
<DISCONTINUED>                              0 <F2>             0 <F2>
<EXTRAORDINARY>                             0 <F2>             0 <F2>
<CHANGES>                                   0 <F2>             0 <F2>
<NET-INCOME>                                0 <F2>             0 <F2>
<EPS-PRIMARY>                               0 <F2>             0 <F2>
<EPS-DILUTED>                               0 <F2>             0 <F2>
        
<FN>
<F1> See March 31, 1998 Statement of Net Assets in Liquidation
<F2> See March 31, 1998 Statement of Changes in Net Assets in Liquidation
</FN>




</TABLE>
Consent of Independent Auditors

We consent to the incorporation by reference in the Registration Statement Form
S-8 (No. 33-99216) and Forms S-3 (Nos. 33-88670 and 33-93812) of Chelsea GCA
Realty, Inc. and Form S-3 (No. 33-98136) of Chelsea GCA Realty, Inc. and Chelsea
GCA Realty Partnership, L.P. and in the related Prospectus of our report dated
February 12, 1997, with respect to the consolidated financial statements and
schedule of Chelsea GCA Realty, Inc. included in this Annual Report (Form 10-K)
for the year ended December 31, 1996.


                                        Ernst & Young LLP

New York, New York
February 12, 1997
I

103D CONGRESS

1ST SESSION H. R. 1694

To suspend until January 1, 1997, the duty on certain chemicals.

IN THE HOUSE OF REPRESENTATIVES

APRIL 5, 1993

Mr. ANDREWS of Texas introduced the following bill; which was referred to

the Committee on Ways and Means

A BILL

To suspend until January 1, 1997, the duty on certain

chemicals.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. DICYCLOPENTENYLOXYETHYL METHACRY4 LATE.

5 Subchapter II of chapter 99 of the Harmonized Tar6 iff Schedule of the United States is amended by inserting

7 in numerical sequence the following new heading:

‘‘ 9902.31.12 Dicyclopentenyloxyethyl methacrylate (CAS

No. 68–586–19–

6) (provided for

in subheading

2916.14.00) ...... Free No change No change On or before

12/31/96 ’’.
2

•HR 1694 IH

1 SEC. 2. 4,5-DICHLOROOCTHILINONE.

2 Subchapter II of chapter 99 of the Harmonized Tar3 iff Schedule of the United States is amended by inserting

4 in numerical sequence the following new heading:

‘‘ 9902.31.13 4,5-Dichloro-2-noctyl-4-

isothiazolin-3-

one (4,5-

dichloroocthilinone) (CAS No.

64359–81–5)

(provided for in

subheading

2934.10.50) ...... Free No change No change On or before

12/31/96 ’’.

5 SEC. 3. PRONAMIDE.

6 Subchapter II of chapter 99 of the Harmonized Tar7 iff Schedule of the United States is amended by inserting

8 in numerical sequence the following new heading:

‘‘ 9902.31.14 3,5-Dichloro-N-

(1,1-dimethyl-2-

propynl) benzamide

(pronamide)

(CAS No.

23950–58–5)

(provided for in

subheading

2924.29.19) ...... Free No change No change On or before

12/31/96 ’’.

9 SEC. 4. MIXTURES OF 4,5-DICHLOROOCTHILINONE AND AP10 PLICATION ADJUVANTS, WITH OR WITHOUT

11 STABILIZERS.

12 Subchapter II of chapter 99 of the Harmonized Tar13 iff Schedule of the United States is amended by inserting

14 in numerical sequence the following new heading:
3

•HR 1694 IH

‘‘ 9902.38.13 Mixtures of 4,5-

Dichloro-2-noctyl-4-

isothiazolin-3-

one (4,5-

dichloroocthilinone) (CAS No.

64359–81–5)

with application

adjuvants, with

or without stabilizers (provided

for in subheading

3808.90.20 or

3808.90.50) ...... Free No change No change On or before

12/31/96 ’’.

1 SEC. 5. MIXTURES OF PRONAMIDE AND APPLICATION

2 ADJUVANTS.

3 Subchapter II of chapter 99 of the Harmonized Tar4 iff Schedule of the United States is amended by inserting

5 in numerical sequence the following new heading:

‘‘ 9902.38.15 Mixtures of 3,5-

Dichloro-N-(1,1-

dimethyl-2-

propynl) benzamide

(pronamide)

with application

adjuvants (CAS

No. 23950–58–

5) (provided for

in subheading

3808.30.10) ...... Free No change No change On or before

12/31/96 ’’.

6 SEC. 6. APPLICABILITY.

7 The amendments made by this Act apply with respect

8 to goods entered, or withdrawn from warehouse for con9 sumption, on or after the 15th day after the date of the

10 enactment of this Act.

Æ
#### STATE OF CONNECTICUT *v.*SCOTT C.

*David T. Grudberg,*in support of the petition.

*Lisa A. Riggione,*senior assistant state’s attorney, in opposition.

Decided June 15, 2010

The defendant’s petition for certification for appeal from the Appellate Court, 120 Conn. App. 26 (AC 29920), is denied.
EXHIBIT 23.2

INDEPENDENT AUDITORS' CONSENT

      We consent to the incorporation by reference in Registration Statement No.
333-76092 of  EarthShell  Corporation  on Form S-3 of our report dated April 29,
2003 (April 13, 2004 as to the one-for-twelve  reverse stock split of EarthShell
Corporation's  common stock) (which report expresses an unqualified  opinion and
includes an explanatory  paragraph relating to EarthShell  Corporation's ability
to continue as a going concern), appearing in this Annual Report on Form 10-K of
EarthShell Corporation for the year ended December 31, 2003.

/s/ Deloitte & Touche LLP

Deloitte & Touche LLP
Los Angeles, California
April 13, 2004
In the United States Court of Federal Claims 

OFFICE OF SPECIAL MASTERS

No. 19-0589V

UNPUBLISHED

SCOTT B. HEARTH, M.D.,

 Petitioner,

v.

SECRETARY OF HEALTH AND 

HUMAN SERVICES,

 Respondent.

Chief Special Master Corcoran 

Filed: July 6, 2020

Special Processing Unit (SPU);

Ruling on Entitlement; Concession;

Table Injury; Tetanus Diphtheria 

acellular Pertussis (Tdap) Vaccine;

Shoulder Injury Related to Vaccine 

Administration (SIRVA)

William E. Cochran, Jr., Black McLaren et al., P.C., Memphis, TN , for petitioner.

Linda Sara Renzi, U.S. Department of Justice, Washington, DC, for respondent.

RULING ON ENTITLEMENT1

On April 22, 2019, Scott B. Hearth, M.D. filed a petition for compensation under 

the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.,

2

(the 

“Vaccine Act”). Petitioner alleges that he suffered a shoulder injury related to vaccine 

administration (“SIRVA”) as a result of a tetanus-diphtheria-acellular pertussis (“Tdap”) 

vaccination he received on June 15, 2016. Petition at 1. The case was assigned to the 

Special Processing Unit of the Office of Special Masters.

On July 6, 2020, Respondent filed his Rule 4(c) report in which he concedes that 

Petitioner is entitled to compensation in this case. Respondent’s Rule 4(c) Report at 1. 

 

1 Because this unpublished ruling contains a reasoned explanation for the action in this case, I am 

required to post it on the United States Court of Federal Claims' website in accordance with the EGovernment Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of 

Electronic Government Services). This means the ruling will be available to anyone with access to 

the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to 

redact medical or other information, the disclosure of which would constitute an unwarranted invasion of 

privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such 

material from public access. 

2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for 

ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 

300aa (2012).
2

Specifically, Respondent concludes that Petitioner’s claim meets the Table criteria for 

SIRVA Id. at 4. Respondent further agrees that “[P]etitioner’s SIRVA and its sequela 

persisted for more than six months after the administration of the vaccine”. Id.

In view of Respondent’s position and the evidence of record, I find that 

Petitioner is entitled to compensation.

IT IS SO ORDERED.

s/Brian H. Corcoran

Brian H. Corcoran

Chief Special Master